The CGM is based on magnetohydrodynamic (MHD) technology, which non-invasively samples interstitial fluid, the body fluid ...

The global continuous glucose monitoring device market is estimated to be valued at USD 12,690.7 million in 2025 and is projected to reach USD 54,553.1 million by 2035, registering a CAGR of 15.7% ...

The gadgets have been revolutionary for many people with diabetes—previously the main available device for measuring blood ...

The market increasingly favours closed-loop tech with extended sensor life, real-time glucose visibility and intelligent ...

A study assessing the use of continuous glucose monitoring in patients with T1D shows significant reductions in A1c and ...

Whether you want to prevent diabetes or enhance your workout routine, this device could be key to staying in top shape.

In Q2 2025 Finland’s medicines agency, FIMEA, granted GlucoModicum authorization to initiate a new clinical investigation under Article 62 of the EU MDR (2017/745), enabling GlucoModicum to generate ...

In the ever-evolving landscape of healthcare technology, the Artificial Pancreas Device System stands out as a beacon of hope ...

Access to continuous glucose monitoring (CGM) devices for blood sugar management can be a challenge. High prices and related costs put this technology out of reach for many people with diabetes.

- DataM IntelligenceAUSTIN, TX, UNITED STATES, June 17, 2025 /EINPresswire / -- The Wearable Continuous Glucose Monitoring Devices Market reached US$ 12.20 billion in 2024 and is expected to reach ...